
Vytala achieves milestone with launch of Seracal & initiates IRB-approved study expanding use in new patient populations
DOWNINGTON, PA, UNITED STATES, March 18, 2025 /EINPresswire.com/ -- Vytala, a healthcare-focused food technology company, today announced a series of key achievements signifying commercial momentum and early market leadership. Following the launch of Seracal in November, monthly sales growth has exceeded 50%, driven by strong clinician interest, patient need, and broad coverage by US healthcare insurers. Dr. Debora Duro, Program Director, Pediatric Gastroenterology, Hepatology and Nutrition at …